EDGAR Filing Documents for 0001144204-17-021105

Form 8-K - Current report:

SEC Accession No. 0001144204-17-021105

Filing Date

2017-04-20

Accepted

2017-04-19 20:48:09

Documents

Period of Report

2017-04-18

Items

Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v464526_8k.htm	8-K	78590
2	EXHIBIT 3.1	v464526_ex3-1.htm	EX-3.1	9336
3	EXHIBIT 3.2	v464526_ex3-2.htm	EX-3.2	6213
4	EXHIBIT 10.1	v464526_ex10-1.htm	EX-10.1	121139
5	EXHIBIT 10.2	v464526_ex10-2.htm	EX-10.2	112460
6	EXHIBIT 10.3	v464526_ex10-3.htm	EX-10.3	120589
7	EXHIBIT 10.4	v464526_ex10-4.htm	EX-10.4	115671
8	EXHIBIT 10.5	v464526_ex10-5.htm	EX-10.5	73927
9	EXHIBIT 16.1	v464526_ex16-1.htm	EX-16.1	2382
10	EXHIBIT 23.1	v464526_ex23-1.htm	EX-23.1	2701
11	EXHIBIT 99.1	v464526_ex99-1.htm	EX-99.1	11082
12	EXHIBIT 99.2	v464526_ex99-2.htm	EX-99.2	258028
13	EXHIBIT 99.3	v464526_ex99-3.htm	EX-99.3	136339
14	EXHIBIT 99.4	v464526_ex99-4.htm	EX-99.4	122225
15	GRAPHIC	spacer.gif	GRAPHIC	43
16	GRAPHIC	pg1img1_ex99-1.jpg	GRAPHIC	5910
	Complete submission text file	0001144204-17-021105.txt		1180911

Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005

Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834

Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)